The Arterium Corporation is designing some promising medicines that could be used in emergency and military medicine, the public relations service of the corporation has told Interfax-Ukraine.

The corporation cannot say when the medicines will start circulating on the market, as the period from designing medicines to their appearance on the market is around three or four years.

The corporation said that Tramix hemostatic drug used in surgeries and gynecology was registered in December 2014. Since the moment of its appearance on the market around 9,000 packages have been shipped.

"Ukrainian medicines are able to satisfy the needs in drugs used in the conflict zone. The corporation's product portfolio has 148 drugs, including modern antibiotics of all key groups and generations and artificial plasma extenders. The medicines were sent military hospitals by way of a grant many times in 2014 and 2015," the corporation said.

Arterium Corporation includes the Kyivmedpreparat manufacturer of antibiotics and Galychpharm, a leader in the production of plant-based drugs. One of the key owners of the corporation is Finance and Credit financial group (Kyiv), controlled by Kostiantyn Zhevaho.